News

Published on 25 Oct 2024 on GuruFocus.com · via Yahoo Finance

Highbridge Capital Management's Strategic Acquisition of Karyopharm Therapeutics...


Article preview image

On September 30, 2024, Highbridge Capital Management LLC made a significant move in the stock market...

NASDAQ.KPTI price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Karyopharm Therapeutics Inc (KPTI) Q3 2024 Earnings Call Highlights: Navigating...

Karyopharm Therapeutics Inc (KPTI) reports steady revenue growth and promising pipeline...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

Karyopharm Therapeutics Inc (KPTI) Q3 2024: Everything You Need To Know Ahead Of...

Karyopharm Therapeutics Inc (NASDAQ:KPTI) is set to release its Q3 2024 earnings on Nov 5, 2024. ...

GuruFocus.com · via Yahoo Finance 4 Nov 2024

Highbridge Capital Management's Strategic Acquisition of Karyopharm Therapeutics...

On September 30, 2024, Highbridge Capital Management LLC made a significant move in the stock mar...

GuruFocus.com · via Yahoo Finance 25 Oct 2024

Karyopharm Therapeutics Inc. (KPTI): Is This One-Dollar Stock a Strong Buy Right...

We recently compiled a list of the 10 Best One-Dollar Stocks To Buy Now. In this article, we are...

Insider Monkey · via Yahoo Finance 21 Jul 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript May 8, 2024 Karyophar...

Insider Monkey via Yahoo Finance 9 May 2024

Insider Sell: President and CEO Richard Paulson Sells 99,844 Shares of Karyopharm Therapeutics ...

President and CEO Richard Paulson executed a sale of 99,844 shares of Karyopharm Therapeutics Inc...

GuruFocus.com via Yahoo Finance 4 Mar 2024

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcript

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcript February 29, 2024 Kar...

Insider Monkey via Yahoo Finance 1 Mar 2024

Karyopharm Therapeutics: Q4 Earnings Snapshot

Karyopharm Therapeutics: Q4 Earnings Snapshot

Washington Post 29 Feb 2024

Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates

Karyopharm Therapeutics (KPTI) came out with a quarterly loss of $0.36 per share versus the Zacks...

Zacks via Yahoo Finance 29 Feb 2024

Karyopharm Therapeutics (NASDAQ:KPTI) adds US$104m to market cap in the past 7 days, though...

It is a pleasure to report that the Karyopharm Therapeutics Inc. (NASDAQ:KPTI) is up 139% in the ...

Simply Wall St. via Yahoo Finance 7 Feb 2024